Skip to main content
. Author manuscript; available in PMC: 2009 Aug 27.
Published in final edited form as: Pharmacogenet Genomics. 2009 Feb;19(2):161–169. doi: 10.1097/FPC.0b013e32831e030e

Fig. 2.

Fig. 2

(a) Phenotypic changes with APOA5_S19W genotypes. Changes (mean ± SE) of high-density lipoprotein (HDL) cholesterol and triglyceride (TG) (y-axis) were growth curve slopes estimated from the mixed models. (b) Absolute changes of TG and HDL with APOA5_S19W genotypes.